Inhibrx Biosciences, Inc. stays a Strong Buy with Q2 2026 ozekibart BLA catalyst, 2026 PFS data, and Ewing sarcoma updates.
VANCOUVER, BC, Jan. 14, 2026 /PRNewswire/ - Thesis Gold Inc. ("Thesis" or the "Company") (TSXV: TAU) (WKN: A3EP87) (OTCQX: ...
VANCOUVER, BC, Jan. 14, 2026 /PRNewswire/ - Thesis Gold Inc. ("Thesis" or the "Company") (TSXV: TAU) (WKN: A3EP87) (OTCQX: THSGF) is pleased to announce the filing ...
HALIFAX, NS / ACCESS Newswire / January 13, 2026 / Namibia Critical Metals Inc. ("Namibia Critical Metals" or the "Company" or "NCMI") (TSXV:NMI)(OTCQB:NMREF) is pleased to announce the filing of the ...
IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a leading precision medicine oncology company, provided a business update including ...
A new clinical study published in the International Journal of Gynecological Cancer reports encouraging results for women ...
Incyte Corporation rated Buy on surging Hem/Onc growth, Monjuvi/Minjuvi catalysts, frontMIND data and strong cash. Click for ...
Follow these tips to help clients draw down their retirement funds in a tax-efficient manner and avoid common mistakes.
In a notable shift in investment strategy, McGuire Investment Group LLC has reduced its stake in Walmart Inc. (NASDAQ: WMT) by selling 16,356 shares, representing a ...
Lost in Time on MSN
Belgium during WW1 in color
Golden Globes 2026: Chalamets only love you when they're chalameting Dog chewing battery-powered heated glove sparks house fire, video shows Trump blasted federal prosecutors at White House event, ...
Celcuity CELC has made significant clinical and regulatory progress in the past few months. In November, Celcuity submitted a new drug application (“NDA”) to the FDA seeking approval for its lead ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback